Julian Huxtable, Partner at Charme Capital Partners, said: “We are delighted to be investing in Prism Healthcare and look forward to working closely with its management team to support the next phase of the Group’s expansion. Charme will also support the Group’s growth via acquisition, both in the UK and internationally. Over the last three years, the business has doubled in size, successfully completing four add-on acquisitions, broadening its product range to become the most comprehensive in the country and expanding into new geographic areas to provide full UK coverage.Ĭharme’s investment will support the Group’s organic expansion through the continued development of its high-quality offering, to help more healthcare professionals provide the very best client care. The Group also has a strong product development pipeline, with a dedicated team continuously improving existing products and developing new ones to improve functionality for both users and carers. Prism Healthcare develops, delivers, installs and services bespoke equipment that delivers vital improvements to the quality of life of its end users, with rapid response times enabled by its UK manufacturing footprint and nationwide team of engineers and assessors. The Group’s customers include both public authorities and private providers, helping healthcare professionals provide excellent care, promote learning, aid movement or recovery, and support independence. Prism Healthcare employs over 650 people and operates from nine UK locations, with a network of international distributors working across UK, EU and global markets. Its products provide healthcare professionals with affordable, clinically effective solutions to help disabled and mobility disadvantaged people remain mobile and active in their own homes, in long term care facilities or in acute care environments. Headquartered in Wakefield, Yorkshire, Prism Healthcare has a diverse portfolio of UK manufactured equipment, including safe patient handling, bathing, accessibility and pressure area care products. Terms of the transaction were not disclosed. As part of the transaction, Limerston will remain invested in the Group, providing long-term stability and support for Prism Healthcare’s continued development, while the management team will also retain a stake in the Group. London, 1 March 2022: Charme Capital Partners (“Charme”), the pan-European mid-market private equity firm, and Limerston Capital (“Limerston”) have announced that Charme IV has acquired Prism Healthcare (or “the Group”), a leading end-to-end provider of specialist healthcare equipment and services. Charme Capital Partners makes investment in Prism Healthcare, a leading UK provider of complex healthcare equipment and services, to support the Group’s further expansion in the UK and internationally.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |